Syner-G BioPharma Group
Stephen F. Coté has a strong background in finance and operations, with extensive experience in leadership roles. Stephen F. is currently serving as the Chief Finance and Operations Officer at Syner-G BioPharma Group, a position they have held since January 2021. Prior to this, they worked as the Chief Financial Officer at smartShift Technologies from January 2020 to January 2021.
From 2010 to 2019, Coté served as the Chief Financial Officer at Lux Research, a global, independent market research and advisory firm. In this role, they provided financial and administrative management to a $28MM firm with operations in the US, Asia, and Europe. Stephen F. implemented financial controls and processes through the implementation of new systems.
Before their time at Lux Research, Coté worked at TowerGroup as the Vice President & Chief Financial Officer from 1998 to 2010. TowerGroup is a business and technology advisory research firm in the financial services industry. During their tenure, they transformed the company into a subsidiary of Reuters, MasterCard Worldwide, and The Corporate Executive Board. Stephen F. established a formal financial management structure and implemented appropriate systems and controls to support the company's growth.
From 1995 to 1998, Coté served as an Office Controller at Mercer Management Consulting, a subsidiary of Marsh & McLennan Companies. Stephen F. supervised the accounting operations and supported divisional controllers while leading Oracle upgrades.
Coté also has experience at Grubb & Ellis Company, a real estate services company, where they served as Vice President & Assistant Controller from 1990 to 1994. At Grubb & Ellis, they managed business planning, forecasting, financial analysis, and transaction processing during a turnaround period.
Stephen F. started their career at Laventhol & Horwath, an international accounting and consulting firm, where they worked as a Senior Accountant from 1984 to 1988. In this role, they performed audit and review engagements, prepared financial statements and tax returns, and provided advisory services on finance and tax matters.
Overall, Stephen F. Coté has a solid work experience in finance and operations, demonstrating their expertise in managing financial functions and supporting business growth in various industries.
Stephen F. Coté has a Bachelor's Degree in Accounting from Bentley University, with a focus on Accounting and Finance. Additionally, they hold an MBA with a specialization in Finance from the University of San Francisco School of Management.
Syner-G BioPharma Group
Syner-G BioPharma Group provides in-depth expertise across the three key elements of Chemistry, Manufacturing, and Controls (CMC): Regulatory Services, Technical Development, and Quality/IT. We call this CMC 360™. We also provide medical writing services, with expertise in authoring a variety of regulatory documents across a wide range of therapeutic areas and in all phases of development. Our regulatory affairs services include the development and implementation of global regulatory strategic plans, regulatory agency meeting support, and electronic submissions to regulatory authorities around the world. We have the skill set and experience to guide your prime asset through any development challenges and along the ever-changing maze of regulatory filing pathways, to a position of full compliance, and high quality. Our expertise spans small molecules, peptides, oligonucleotides, biologics, monoclonal antibodies, antibody-drug conjugates, and cell and gene therapy products.